Inventor · disambiguated record
Li Xing
Also filed as: XING LI · XING LI H · XING LI HUANG
29 granted patents·18 pending applications·142 citations·filing 2003–2022
95Inventor score
Files withPFIZER31ACURX PHARMACEUTICALS LLC4PHARMACIA CORP2SHANGHAI INST MATERIA MEDICA CAS2TECHNODERMA MEDICINES PTE LTD2
Top patents by PatentIndex Score
47 records- 0195US9663526B2Aminopyrimidinyl compoundsPFIZER·Filed 2015·Granted May 30, 2017·22 cites·26 claims
- 0292US11197867B2Aminopyrimidinyl compoundsPFIZER·Filed 2020·Granted Dec 14, 2021·2 cites·9 claims
- 0390US7067540B2Substituted pyridinonesPHARMACIA CORP·Filed 2003·Granted Jun 27, 2006·44 cites·45 claims
- 0489US10144738B2Pyrazolo[1,5-A]PYRAZIN-4-YL derivativesPFIZER·Filed 2017·Granted Dec 4, 2018·7 cites·24 claims
- 0587US7259266B2Benzopyran compounds useful for treating inflammatory conditionsPHARMACIA CORP·Filed 2004·Granted Aug 21, 2007·38 cites·1 claims
- 0686US10463675B2Aminopyrimidinyl compoundsPFIZER·Filed 2017·Granted Nov 5, 2019·4 cites·2 claims
- 0785US10980815B2Aminopyrimidinyl compoundsPFIZER·Filed 2019·Granted Apr 20, 2021·2 cites·8 claims
- 0885US10308615B2Heterocyclic compounds as inhibitors of Vanin-1 enzymePFIZER·Filed 2016·Granted Jun 4, 2019·3 cites·8 claims
- 0983US9670201B2Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereofPFIZER·Filed 2015·Granted Jun 6, 2017·3 cites·14 claims
- 1082US10426135B2Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereofPFIZER·Filed 2019·Granted Oct 1, 2019·2 cites·7 claims
- 1181US10266513B2Bruton's tyrosine kinase inhibitorsPFIZER·Filed 2017·Granted Apr 23, 2019·2 cites·6 claims
- 1281US7629363B2Diaryl substituted pyridinonesPFIZER·Filed 2005·Granted Dec 8, 2009·5 cites·31 claims
- 1380US12129256B2Pyrazolo[1,5-a]pyrazin-4-yl derivativesPFIZER·Filed 2022·Granted Oct 29, 2024·0 cites·4 claims
- 1477US10227346B2Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therofPFIZER·Filed 2018·Granted Mar 12, 2019·1 cites·4 claims
- 1574US9284283B2Macrocyclic compounds for modulating IL-17ENSEMBLE THERAPEUTICS CORP·Filed 2013·Granted Mar 15, 2016·3 cites·16 claims
- 1674US2021377495A1Aminopyrimidinyl compoundsPFIZER·Filed 2021·Application pending·0 cites
- 1770US11472809B2Pyrazolo[1,5-a]pyrazin-4-yl derivativesPFIZER·Filed 2020·Granted Oct 18, 2022·0 cites·4 claims
- 1870US10822341B2Pyrazolo[1,5-a]pyrazin-4-yl derivativesPFIZER·Filed 2018·Granted Nov 3, 2020·0 cites·23 claims
- 1970US10385036B2Sulfonamide-substituted indole modulators of RORC2 and methods of use thereofPFIZER·Filed 2016·Granted Aug 20, 2019·1 cites·13 claims
- 2069US12509447B2Small molecule compoundTECHNODERMA MEDICINES PTE LTD·Filed 2020·Granted Dec 30, 2025·1 cites·9 claims
- 2169US10723741B1DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2019·Granted Jul 28, 2020·0 cites·11 claims
- 2269US2022112195A1DNA Polymerase IIIC Inhibitors and Use ThereofACURX PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 2368US11001592B2DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2020·Granted May 11, 2021·0 cites·17 claims
- 2468US10336748B2Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereofPFIZER·Filed 2016·Granted Jul 2, 2019·1 cites·11 claims
- 2568US2021002251A1Bruton's Tyrosine Kinase InhibitorsPFIZER·Filed 2020·Application pending·0 cites
- 2667US10836772B2DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2020·Granted Nov 17, 2020·0 cites·6 claims
- 2767US2020039960A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2019·Application pending·0 cites
- 2866US10815213B2Bruton's tyrosine kinase inhibitorsPFIZER·Filed 2019·Granted Oct 27, 2020·0 cites·4 claims
- 2965US2019144429A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2019·Application pending·0 cites
- 3065US2019387710A1Methyl- and Trifluromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use ThereofPFIZER·Filed 2019·Application pending·0 cites
- 3163US2016046597A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2014·Application pending·0 cites
- 3263US2018282304A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2018·Application pending·0 cites
- 3362US2018086736A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2017·Application pending·0 cites
- 3461US8686185B2Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their saltsGWAG BYOUNG JOO·Filed 2008·Granted Apr 1, 2014·1 cites·8 claims
- 3560US2017233371A1Rorc2 inhibitors and methods of use thereofPFIZER·Filed 2017·Application pending·0 cites
- 3659US2015291554A1Bruton's Tyrosine Kinase InhibitorsPFIZER·Filed 2013·Application pending·0 cites
- 3757US2019292157A1Novel heterocyclic compounds as inhibitors of vanin-1 enzymePFIZER·Filed 2019·Application pending·0 cites
- 3854US12384795B2Pyrimido[5,4-b]pyrrolizin compound, optical isomer thereof, preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Granted Aug 12, 2025·0 cites·14 claims
- 3953US2007088033A1Diaryl Substituted PyridinonesDEVADAS BALEKUDRU·Filed 2006·Application pending·0 cites
- 4044US11254668B2Pyrazolo[1,5-A]pyrazin-4-yl and related derivativesPFIZER·Filed 2018·Granted Feb 22, 2022·0 cites·10 claims
- 4144US2005176775A1Substituted pyridinonesFiled 2004·Application pending·0 cites
- 4243US2005148627A1Benzopyran compounds for use in the treatment and prevention of inflammation related conditionsFiled 2004·Application pending·0 cites
- 4341US11834432B2Substituted amino six-membered nitric heterocyclic ring compound and preparation and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Granted Dec 5, 2023·0 cites·16 claims
- 4439US2009215817A1Novel Triazolopyridine Compounds for the Treatment of InflammationPFIZER·Filed 2005·Application pending·0 cites
- 4539US2009209577A1Novel Triazolopyridine CompoundsPFIZER·Filed 2005·Application pending·0 cites
- 4638US2024174648A1Small Molecule CompoundTECHNODERMA MEDICINES PTE LTD·Filed 2020·Application pending·0 cites
- 4734US10493129B2Use of fibroblast growth factor 2BEIJING INST OF MICROBIOLOGY AND EPIDEMIOLOGY·Filed 2013·Granted Dec 3, 2019·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Li Xing files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →